multi-peptide-and-growth-factor-serum Thrombin receptor agonist peptides (TRAPs) are synthetic molecules designed to mimic the action of thrombin at its specific receptor, primarily the Protease-Activated Receptor 1 (PAR-1). These peptides are crucial tools in research, enabling scientists to study platelet aggregation, secretion, and signaling pathways without the complex effects of thrombin itself.Immobilized Thrombin Receptor Agonist Peptide ... The primary function of a thrombin receptor agonist peptide is to activate the thrombin receptor, leading to downstream cellular responses, most notably in plateletsHigh-purityThrombin ReceptorActivator forPeptide5 (TRAP-5), a potent PAR1agonistpromoting platelet aggregation, offered by APExBIO for reliable ....
Thrombin is a vital enzyme in the blood coagulation cascade, playing a central role in hemostasis作者：BH Chao·1992·被引用次数：132—Tritiated photoactivatable analogs of the native humanthrombin receptor(PAR‐1)agonist peptide, SFLLRN‐NH 2. The Journal ofPeptideResearch 2001, 57 (6) , .... It exerts many of its effects by binding to specific receptors on the surface of cells, particularly platelets. The thrombin receptor, a G-protein-coupled receptor, is activated when thrombin cleaves an extracellular segment, exposing a new N-terminus that then acts as a tethered ligand, binding to the receptor itself. This activation initiates intracellular signaling cascades.
TRAPs are engineered to bypass the initial cleavage step by thrombin. Instead, they directly bind to the newly exposed tethered ligand site or a similar site on the receptor, effectively acting as a direct agonist. This direct activation allows researchers to isolate and study the specific cellular responses mediated by the thrombin receptor, particularly PAR-1, in a controlled manner.
The core mechanism of action for a thrombin receptor agonist peptide involves binding to and activating the thrombin receptor, most commonly PAR-1.作者：T Nose·1998·被引用次数：21—agonist peptide. Biochem. Biophys. Res. Commun. 184, 790-796. 5. Chao ...thrombin receptor antagonist peptides. J. Med. Chem. 39, 4879-. 4887. 15. Ahn ... This activation triggers a series of intracellular events, including:
* Platelet Aggregation: This is one of the most well-documented effects of TRAPs. They induce platelets to clump together, a critical step in blood clot formation.
* Platelet Secretion: Activated platelets release various molecules stored in their granules, such as ADP, serotonin, and growth factors. TRAPs stimulate this release.Thrombin Receptor Activating Peptide - an overview
* Signal Transduction: Activation of the thrombin receptor leads to the activation of intracellular signaling pathways, such as those involving G proteins and downstream kinases, which mediate cellular responses.The cleaved peptide of the thrombin receptor is a strong ...
These properties make TRAPs invaluable in various research settings:
* Platelet Function Studies: TRAPs are widely used *in vitro* to investigate the mechanisms of platelet activation, aggregation, and secretion. They serve as reliable stimuli for assessing platelet responsiveness.
* Drug Discovery: Researchers utilize TRAPs to screen for potential drugs that might modulate thrombin receptor activity, such as thrombin receptor antagonist peptides which could have antithrombotic effects.
* Physiological Research: They help elucidate the role of thrombin receptor signaling in various physiological processes beyond coagulation, including inflammation, wound healing, and cell proliferation.
Several specific TRAPs have been developed and characterized, often differing in their amino acid sequences and lengths. Common examples include:
* TRAP-6 (Thrombin Receptor Activator Peptide 6): A hexapeptide often used for its potent agonist activity.
* TRAP-7 amide (SFLLRNP-NH2): A synthetic heptapeptide that effectively activates the human thrombin receptor.TRAP, or thrombin receptor activating peptide, is a synthetic peptide that mimics the N-terminal sequence of the tethered ligand formed after thrombin ...
* TRAP-14: A longer peptide sequence designed to activate the $\alpha$-thrombin receptor.
These peptides are synthesized with high purity and are often supplied as lyophilized solids for stability. Variations in sequence can influence their efficacy, selectivity for different PAR receptor subtypes, and duration of action. While TRAPs are generally considered full agonists, some studies suggest that certain synthetic peptides might not be full agonists in the same way thrombin itself is, highlighting the nuanced nature of receptor activation.
It is crucial to understand the distinction between thrombin and thrombin receptor agonist peptides. Thrombin is a complex enzyme with multiple biological roles, including its procoagulant activity344220. The FormylPeptide Receptor-Like 1Antagonist, WRW⁴ controls the biological activity of FormylPeptide Receptor-Like 1. View Pricing.. TRAPs, in contrast, are specifically designed to target and activate the thrombin receptor, primarily PAR-1. This specificity allows researchers to study the effects of receptor activation in isolation, avoiding the confounding effects of thrombin's other enzymatic activitiesThrombin ReceptorActivatorPeptide6 (TRAP-6),also called Selective Protease-ActivatedReceptor1 (PAR-1)Agonist,is an hexapeptide fragment of thethrombin.... While TRAPs mimic the receptor-activating function of thrombin, they do not possess its enzymatic propertiesThrombin Receptor Agonist (FLLRN) - 5 mg.
When using thrombin receptor agonist peptides in research, factors such as concentration (e.g., EC50 values are often reported), purity, and stability are important considerations. The choice of a specific TRAP may depend on the experimental design and the receptor subtype being investigated.Thrombin Receptor Agonist Peptide
The ongoing research into TRAPs and their interactions with thrombin receptors continues to deepen our understanding of hemostasis, thrombosis, and related physiological processes. The development of highly selective agonist peptides and their antagonists holds significant promise for therapeutic interventions in cardiovascular diseases and other conditions where thrombin receptor signaling plays a critical role.Thisthrombin receptor agonist peptideis a PAR-1 antagonist peptide. Specifications. Chemistry. Sequence one letter code. FLLRN. Sequence ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.